Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma: a Randomized Double-blind Controlled Clinical Trial

NCT01745302 is registered in ClinicalTrials.gov with Shanghai University of Traditional Chinese Medicine as lead sponsor.

NCT NCT01745302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01745302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma: a Randomized Double-blind Controlled Clinical Trial
Lead sponsor
Shanghai University of Traditional Chinese Medicine
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2011
Completion date
December 31, 2016
Enrollment
470 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer